表紙:アブレーション装置の世界市場:業界動向、シェア、規模、成長、機会、予測(2021年~2026年)
市場調査レポート
商品コード
1046173

アブレーション装置の世界市場:業界動向、シェア、規模、成長、機会、予測(2021年~2026年)

Ablation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 143 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
アブレーション装置の世界市場:業界動向、シェア、規模、成長、機会、予測(2021年~2026年)
出版日: 2021年12月10日
発行: IMARC Services Private Limited
ページ情報: 英文 143 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のアブレーション装置の市場規模は、2015年から2020年にかけて力強い成長を示しました。2021年から2026年にかけて市場は約11%のCAGRで成長すると予想されています。

癌、心房細動、慢性静脈不全などの生命を脅かす疾患の増加は、市場の成長を促進する重要な要因の一つと考えられます。また、不整脈や不整脈の原因となる異常組織を除去するための電気生理学的手法の普及も、市場の成長に寄与しています。さらに、ロボットナビゲーションシステムを搭載した次世代アブレーション装置の開発など、さまざまな製品イノベーションも成長を促す要因となっています。

当レポートでは、世界のアブレーション装置市場について調査しており、市場分析、価格分析、競合情勢など、包括的な情報を提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のアブレーション装置市場

  • 市場概要
  • 市場実績
  • COVID-19の影響

第6章 市場セグメンテーション:装置技術別

  • 高周波デバイス
  • レーザー/光アブレーション
  • 超音波装置
  • 冷凍アブレーション装置
  • その他

第7章 市場セグメンテーション:アプリケーション別

  • がん治療
  • 心血管疾患の治療
  • 眼科治療
  • 婦人科治療
  • 泌尿器科治療
  • 美容整形
  • その他

第8章 市場セグメンテーション:エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第9章 市場セグメンテーション:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東とアフリカ
    • 市場セグメンテーション:国別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業プロファイル
    • Abbott Laboratories
    • AngioDynamics Inc.
    • AtriCure Inc.
    • Boston Scientific Corporation
    • CONMED Corporation
    • Elekta AB(publ)
    • Johnson & Johnson
    • Medtronic plc
    • Olympus Corporation
    • Smith & Nephew plc
目次
Product Code: SR1020H232_Report

The global ablation devices market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 11% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Ablation devices are minimally invasive (MI) medical instruments used for the removal, or excision, or abnormal body tissues for therapeutic purposes. Some of the commonly used ablation devices include temperature-controlled, fluid-cooled, robotic catheter manipulation and laser ablators, tissue contact and spray probes and balloon ablation devices. They operate using radiofrequency (RF), laser, ultrasound, cryoablation, microwave and hydrothermal technologies. They are used as an alternative to surgical treatment for various chronic diseases and the removal of cancerous tumors and kidney stones. Ablation devices are also utilized for the management of chronic lower back, neck and arthritis pain. As a result, they find extensive applications in the treatment of ophthalmological, oncological, gynecological, urological and cardiovascular disorders.

Ablation Devices Market Trends:

  • The increasing prevalence of life-threatening diseases, such as cancer, atrial fibrillation and chronic venous insufficiency (CVI), is one of the key factors driving the growth of the market. Moreover, rising awareness among the masses regarding the availability of effective ablation procedures is providing a thrust to the market growth. Minimally invasive ablation procedures cause lesser pain, scarring, discomfort and promote faster recovery in the patients. In line with this, the widespread adoption of electrophysiology to remove abnormal tissues that cause irregular heart rhythms or cardiac arrhythmia is also contributing to the growth of the market. Additionally, various product innovations, such as the development of next-generation ablation devices with robotic navigation systems, are acting as other growth-inducing factors. Product manufacturers are developing non-thermal, non-tumescent and non-sclerosant endovenous ablation devices for the effective treatment of superficial vein reflux. Other factors, including rising healthcare expenditure capacities of the consumers, along with significant improvements in the medical industry, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global ablation devices market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on device technology, application and end user.

Breakup by Device Technology:

  • Radiofrequency Devices
  • Laser/Light Ablation
  • Ultrasound Devices
  • Cryoablation Devices
  • Others

Breakup by Application:

  • Cancer Treatment
  • Cardiovascular Disease Treatment
  • Ophthalmologic Treatment
  • Gynecological Treatment
  • Urological Treatment
  • Cosmetic Surgery
  • Others

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AngioDynamics Inc., AtriCure Inc., Boston Scientific Corporation, CONMED Corporation, Elekta AB (publ), Johnson & Johnson, Medtronic plc, Olympus Corporation and Smith & Nephew plc. Key Questions Answered in This Report:

  • How has the global ablation devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global ablation devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the device technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global ablation devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Ablation Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Technology

  • 6.1 Radiofrequency Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Laser/Light Ablation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Ultrasound Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cryoablation Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Cancer Treatment
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiovascular Disease Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ophthalmologic Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Gynecological Treatment
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Urological Treatment
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Cosmetic Surgery
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AngioDynamics Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 AtriCure Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Boston Scientific Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 CONMED Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Elekta AB (publ)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Olympus Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Smith & Nephew plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis